TGFBR1 and cancer: We then assessed whether this sNF96.2-induced effect was TGFβ-dependent, and showed that SB-431542, a potent cell-permeable and selective inhibitor of the TGFβ type I-receptor (TβRI), abrogated Capan-2 cancer cell migration towards sNF96.2 cells (Fig. 1a).